What to Do After Your First CRL from the FDA: A Story of Turning Setbacks into Success
Introduction Imagine you’re a regulatory scientist at a pharmaceutical company. Your team has worked tirelessly for years, conducting clinical trials, collecting data, and finally submitting your New Drug Application (NDA) to the FDA. The anticipation builds as you await their decision, only to receive a Complete Response Letter (CRL). It feels like a punch to […]